Your trusted source for investing success

Tag: Phase

10+ Gold Stocks to Watch

Stocks.
Expert Insights.
Industry Stats.



Give me my free report!

Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy

Apellis Pharmaceuticals (Nasdaq:APLS), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of autoimmune diseases, today will provide an update with 18-month data on its Phase 2 trial (FILLY) of its complement C3 inhibitor, APL-2, in patients with geographic atrophy (GA) associated with age-related macular degeneration

ABLYNX ANNOUNCES 2017 FULL YEAR RESULTS

Ablynx (Nasdaq: ABLX) today announced its financial results for the year ended 31st December 2017, which have been prepared in accordance with IFRS as issued by the IASB and adopted by the European Union, business highlights year-to-date and the outlook for the remainder of the year.

As quoted in the press release:
Dr Edwin

10+ Gold Stocks to Watch

Stocks.
Expert Insights.
Industry Stats.



Give me my free report!
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Big News Roundup: Alliance Growers Announces Closing of Investment in New Maple Holdings Ltd, Solaris Nutraceuticals and Southern Cross University Team Up for Pain Relief Joint Venture, Invictus’ Acreage Pharms’ Acquires 23 New Strains

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/big-news-roundup-cannabis/